360° SearchNetwork Hot Spots Trends Time Series

Advanced Search Options >>

maintenance therapy

Type: Keyphrase

Name: maintenance therapy

First reported May 17 2013 - Updated May 17 2013 - 1 reports

capecitabine

Study Findings from G. Bisagni et al Broaden Understanding of Breast Cancer

(NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Investigators publish new report on Breast Cancer. According to news reporting originating from Cremona, Italy, by NewsRx correspondents, research stated, "Therapeutic approach ... [Published NewsRX - May 17 2013]

Entities: Breast Cancer, bevacizumab, Cremona (Italy), capecitabine, maintenance therapy

First reported May 13 2013 - Updated May 14 2013 - 1 reports

FDA Food & Drug Administration

FDA Approves New Combination Drug for COPD

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.By Kristin J. KelleyThe FDA has approved a new dry powder inhaler (marketed as Breo Ellipta) to increase airflow and reduce exacerbations in patients ... [Published AIDS Clinical Care - May 13 2013]

Entities: Chronic Obstructive Pulmonary Disease, Drugs, FDA Food & Drug Administration, Ellipta, BREO (Drug)

First reported May 10 2013 - Updated May 10 2013 - 1 reports

Hypertension drug shows schizophrenia promise

medwireNews: Results from a proof-of-concept study point to a role for sodium nitroprusside in the treatment of schizophrenia.A single intravenous dose of the drug, which is approved for the treatment of severe hypertension, led to a rapid and long-lasting ... [Published MedWire News - May 10 2013]

Entities: Nitric Oxide, NMDA, Hypertension

First reported May 08 2013 - Updated May 08 2013 - 1 reports

Burden of symptoms could guide NSCLC pemetrexed use

medwireNews: Symptom burden and performance status may help identify the patients with non-squamous non-small-cell lung cancer (NSCLC) who are likely to respond to maintenance pemetrexed therapy, phase III trial findings suggest.The post hoc analysis ... [Published MedWire News - May 08 2013]

Entities: Pemetrexed, non-small cell lung cancer, progression-free survival, Patient, Encumbrance

First reported May 08 2013 - Updated May 08 2013 - 1 reports

carboplatin

S-1 combination regimen effective for NSCLC

medwireNews: Researchers suggest that combined therapy with the fluoropyrimidine S-1, carboplatin, and bevacizumab followed by maintenance therapy with S-1 and bevacizumab should be first-line treatment for patients with advanced non-squamous non-small-cell ... [Published MedWire News - May 08 2013]

Entities: bevacizumab, non-small cell lung cancer, carboplatin, maintenance therapy

First reported May 07 2013 - Updated May 07 2013 - 1 reports

Herceptin

HERA Trial: Invasive Lobular Breast Carcinoma Patients Derived Same Benefit From Trastuzumab Maintenance

Patients with invasive lobular breast cancer who participated in the HERA (Herceptin Adjuvant) trial derived similar benefits from 1 year of trastuzumab maintenance therapy as those patients with invasive ductal carcinoma. The results are published in ... [Published Cancernetwork.com - May 07 2013]

Entities: Herceptin, maintenance therapy, Patient, Ductal Carcinoma

First reported May 06 2013 - Updated May 06 2013 - 1 reports

Campath, Calcineurin Inhibitor Reduction and Chronic Allograft Nephropathy (3C) Study: background, ...

Kidney transplantation is the best treatment for patients with end-stage renal failure, but uncertainty remains about the best immunosuppression strategy. Long-term graft survival has not improved substantially, and one possible explanation is calcineurin ... [Published 7thSpace - May 06 2013]

Entities: Campath, induction therapy, maintenance therapy

First reported Apr 30 2013 - Updated Apr 30 2013 - 1 reports

Continuous circular cycling ‘a distinct bipolar disorder subtype’

medwireNews: Results from an Italian study suggest that there are distinct differences in clinical presentation, outcome, and treatment response between bipolar disorder patients with and without intervals between mood episodes.Indeed, in a study of 140 ... [Published MedWire News - Apr 30 2013]

Entities: Bipolar Disorder, Patient, sodium thiosulfate

First reported Apr 30 2013 - Updated Apr 30 2013 - 1 reports

Efficacy and Safety of Busulfan-Based Conditioning Regimens for Multiple Myeloma

Multiple myeloma is a malignancy of B cells characterized by accumulation of abnormal plasma cells in the bone marrow. In the past 20 years, the use of high-dose therapies and novel agents has resulted in significant and meaningful improvements in survival. ... [Published The Oncologist - Apr 30 2013]

Entities: Multiple Myeloma, consolidation therapy, busulfan, Patient, Autologous Stem Cell Transplant

First reported Apr 27 2013 - Updated Apr 27 2013 - 1 reports

Rituximab May Speed Remission in Refractory Lupus Nephritis

Jónsdóttir T, Zickert A, Sundelin B et al. Long-term follow-up in lupus nephritis patients treated with rituximab--clinical and histopathological response. Rheumatology (2013) 52:847-855A small clinical trial from Sweden shows that the B-cell-depleting ... [Published Consultant Live - Apr 27 2013]

Entities: rituximab, Patient, mycophenolate mofetil

First reported Apr 25 2013 - Updated Apr 25 2013 - 1 reports

Man gets house arrest

A 25-year-old Six Nations man was sentenced Wednesday to time served plus a conditional sentence of eight months after earlier pleading guilty in Ontario Court to possession over $5,000, possession of break-in tools and breach of recognizance.Tyler R. ... [Published Brantford Expositor - Apr 25 2013]

Entities: House Arrest, maintenance therapy, Six Nations Championship, Probation

First reported Apr 16 2013 - Updated Apr 16 2013 - 1 reports

Medicare coverage of 'maintenance therapy' determined by need for skilled care, CMS clarifies in Jimmo document

Providers must sufficiently document the need for skilled care in order to obtain Medicare coverage for so-called “maintenance therapy,” the Centers for Medicare & Medicaid Services stressed in a recent fact sheet on the Jimmo v. Sebelius settlement ... [Published McKnight's Long Term Care News - Apr 16 2013]

Entities: Medicare, maintenance therapy, Centers for Medicare & Medicaid Services, Adjudication

Quotes

"With the filing of the preliminary proxy, we have achieved an important interim step towards completing the merger with Immune, which is now anticipated to occur in the third quarter of 2013. "In the meantime""

EpiCept Reports First Quarter 2013 Operating and Financial Results [Published Business Wire - 10 hours ago]

...According to news reporting originating from Cremona, Italy, by NewsRx correspondents, research stated, "Therapeutic approach for patients with metastatic breast cancer (MBC) is still controversial. This study was conducted to assess the efficacy and safety of bevacizumab in combination with docetaxel plus capecitabine as first-line treatment for MBC."

Study Findings from G. Bisagni et al Broaden Understanding of Breast Cancer [Published NewsRX - May 17 2013]

...According to news reporting out of Basel, Switzerland, by NewsRx editors, research stated, "Maintenance therapy can delay progression and prolong survival in metastatic non-small-cell lung cancer (mNSCLC). As treatment for mNSCLC is non-curative, its impact on patient health-related quality of life (HRQoL) is an important consideration."

Reports from F. Hoffmann-La Roche Add New Data to Findings in Lung Cancer [Published NewsRX - May 17 2013]

...30% of patients with non-small cell lung cancer, Roche CMO Hal Barron, who also heads up Genentech Global Product Development, said in a statement. "People with this type of lung cancer now have the option to use a personalized medicine as their initial treatment" he said

Roche wins new targeted OK for Tarceva in EGFR-positive lung cancer [Published FiercePharma - May 15 2013]

More Content

sort by: Date \| Relevance
Sunovion Presents Results from a One-year, Larg... [Published Business Wire - 1 hour ago]
EpiCept Reports First Quarter 2013 Operating an... [Published Business Wire - 10 hours ago]
Treatment of fungal myositis with intra-lesiona... [Published 7thSpace - 20 hours ago]
Study Findings from G. Bisagni et al Broaden Un... [Published NewsRX - May 17 2013]
Reports from F. Hoffmann-La Roche Add New Data ... [Published NewsRX - May 17 2013]
Finding a way out of addiction [Published Recorder.com - May 17 2013]
Novel Two-step Immunotherapy Shows Promise in R... [Published CancerConnect.com - May 17 2013]
FDA Approves Erlotinib (Tarceva) as First-Line ... [Published Cancernetwork.com - May 17 2013]
FDA Approves APOQUEL® (oclacitinib tablet) to C... [Published Stockwatch - May 16 2013]
AstraZeneca issues update on accelerated oncolo... [Published European Pharmaceutical Review - May 16 2013]
New data to be presented at the 2013 ASCO Annua... [Published Live-PR.com - May 16 2013]
New data to be presented at the 2013 ASCO Annua... [Published PR inside - May 16 2013]
Roche wins new targeted OK for Tarceva in EGFR-... [Published FiercePharma - May 15 2013]
Tarceva and EGFR Mutation Test get US FDA Appr... [Published ITechPost - May 15 2013]
Utilising Real Time Disease Management to Augme... [Published eyeforpharma.com - May 15 2013]
FDA Approves Frontline Erlotinib With Novel Com... [Published OncLive - May 15 2013]
Genentech to Present Important New Data Reflect... [Published EquityJungle - v0.1 - May 15 2013]
Glaxo/THRX's Breo Ellipta Gets FDA Nod Zacks [Published Yahoo! Finance - May 13 2013]
FDA Approves New Combination Drug for COPD [Published AIDS Clinical Care - May 13 2013]
GSK wins US approval for Seretide successor Bre... [Published PMLive - May 13 2013]
Toenail fungus infection in 15-year-old [Published Orthopedics Today - May 10 2013]
Hypertension drug shows schizophrenia promise [Published MedWire News - May 10 2013]
Natural Solutions to Chronic Stomach Problems..... [Published Pro Health Network - May 10 2013]
Upcoming Catalysts Could Push ChemoCentryx To D... [Published Seeking Alpha - May 10 2013]
Clinical Review: Seborrhoeic dermatitis [Published GP Online - May 10 2013]
New online resource for information on large an... [Published Dearborn Press & Guide - May 09 2013]
S-1 combination regimen effective for NSCLC [Published MedWire News - May 08 2013]
Burden of symptoms could guide NSCLC pemetrexed... [Published MedWire News - May 08 2013]
HERA Trial: Invasive Lobular Breast Carcinoma P... [Published Cancernetwork.com - May 07 2013]
Campath, Calcineurin Inhibitor Reduction and Ch... [Published 7thSpace - May 06 2013]

Blogs

sort by: Date \| Relevance
Genentech to Present Important New Data Reflect... [Published EquityJungle - v0.1 - May 15 2013] Filed under: Investing Genentech to Present Important New Data Reflecting Broad Cancer Pipeline at ASCO -- First Phase III Data on Obinutuzumab (GA101) in one of the Most Commonly Diagnosed Blood Cancers -- -- Early Stage Data on Investigational ...
4 Healthcare Stock Stories for Midweek Investme... [Published Wall St. Cheat Sheet - Apr 10 2013] Synergy Pharmaceuticals ( NASDAQ:SGYP ): Current price $6.36 On Tuesday, Synergy announced that it will offer to sell a total value of $90 million worth of its common stock in an underwritten public offering, or an aggregate value of $103.5 million ...
4 Healthcare Stock Stories for Almost-The-Weeke... [Published Wall St. Cheat Sheet - Feb 01 2013] Pfizer ( NYSE:PFE ): Closing price $27.28 Zoetic, which is Pfizer’s animal health spin-off, has priced its initial public offering at $26 per share, which is a bit above the expected $22 to $25 range. The shares will likely be traded on the New York ...
DJIA Week in Review: GE Ups Share Buyback, JPMo... [Published Wall St. Cheat Sheet - Dec 15 2012] Here’s your Cheat Sheet to the week in Dow 30 business news: Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >> The Walt Disney Company’s ( NYSE:DIS ) Club Penguin changed ...
Microsoft’s Windows 8 Resilient to Piracy and 2... [Published Wall St. Cheat Sheet - Dec 14 2012] Merck & Co. ( NYSE:MRK ) and Ariad Pharmaceuticals ( NASDAQ:ARIA ) are co-developing Jenzyl which is a trade name for ridaforolimus, a maintenance treatment of patients with metastatic soft tissue sarcoma or bone sarcoma previously treated with chemotherapy, ...

Press Releases

sort by: Date \| Relevance
Sunovion Presents Results from a One-year, Larg... [Published Business Wire - 1 hour ago]
EpiCept Reports First Quarter 2013 Operating an... [Published Business Wire - 10 hours ago]
New data to be presented at the 2013 ASCO Annua... [Published PR inside - May 16 2013]
Cell Therapeutics Announces Data Safety and Mon... [Published PR Newswire: Health - Jan 31 2013]
Presentations Highlight Data on VELCADE® (borte... [Published EON Health & Medicine - Dec 09 2012]